Impact of intravitreal pharmacotherapies including antivascular endothelial growth factor and corticosteroid agents on diabetic retinopathy-Reference-Cited by-同舟云学术

Impact of intravitreal pharmacotherapies including antivascular endothelial growth factor and corticosteroid agents on diabetic retinopathy

Published:2017-05 Issue:3 Volume:28 Page:213-218
ISSN:1040-8738
Container-title:Current Opinion in Ophthalmology
language:en
Short-container-title:

Author:

Wykoff Charles C.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference26 articles.

1. The prevalence of diabetic retinopathy among adults in the United States;Kempen;Arch Ophthalmol,2004

2. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to 2010;Leasher;Diabetes Care,2016

3. Causes of vision loss worldwide, 1990-2010: a systematic analysis;Bourne;Lancet Glob Health,2013

4. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group.;Ophthalmology,1981

5. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema;Elman;Ophthalmology,2010

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resilience to diabetic retinopathy;Progress in Retinal and Eye Research;2024-07

2. Recent advances in the treatment and delivery system of diabetic retinopathy;Frontiers in Endocrinology;2024-02-15

3. Diabetes mellitus and its influence on the incidence and process of diabetic retinopathy;Central European Journal of Public Health;2023-12-31

4. Effect of Bone Marrow Mesenchymal Stem Cells on a Short-Term Induced Diabetic Retinopathy in Adult Female Albino Rats;Regenerative Engineering and Translational Medicine;2023-07-17

5. Tailoring surface properties of liposomes for dexamethasone intraocular administration;Journal of Controlled Release;2023-02